These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30008718)

  • 1. Pre-Activation of Toll-Like Receptor 2 Enhances CD8
    Lin Y; Huang X; Wu J; Liu J; Chen M; Ma Z; Zhang E; Liu Y; Huang S; Li Q; Zhang X; Hou J; Yang D; Lu M; Xu Y
    Front Immunol; 2018; 9():1495. PubMed ID: 30008718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poly(I:C) treatment leads to interferon-dependent clearance of hepatitis B virus in a hydrodynamic injection mouse model.
    Wu J; Huang S; Zhao X; Chen M; Lin Y; Xia Y; Sun C; Yang X; Wang J; Guo Y; Song J; Zhang E; Wang B; Zheng X; Schlaak JF; Lu M; Yang D
    J Virol; 2014 Sep; 88(18):10421-31. PubMed ID: 24920792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kupffer Cells Support Hepatitis B Virus-Mediated CD8+ T Cell Exhaustion via Hepatitis B Core Antigen-TLR2 Interactions in Mice.
    Li M; Sun R; Xu L; Yin W; Chen Y; Zheng X; Lian Z; Wei H; Tian Z
    J Immunol; 2015 Oct; 195(7):3100-9. PubMed ID: 26304988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The IL-1R/TLR signaling pathway is essential for efficient CD8
    Ma Z; Liu J; Wu W; Zhang E; Zhang X; Li Q; Zelinskyy G; Buer J; Dittmer U; Kirschning CJ; Lu M
    Cell Mol Immunol; 2017 Dec; 14(12):997-1008. PubMed ID: 28757610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toll-like receptor 2 promotes T helper 17 cells response in hepatitis B virus infection.
    Zhao RR; Yang XF; Dong J; Zhao YY; Wei X; Huang CX; Lian JQ; Zhang Y
    Int J Clin Exp Med; 2015; 8(5):7315-23. PubMed ID: 26221271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contribution of Toll-like receptors to the control of hepatitis B virus infection by initiating antiviral innate responses and promoting specific adaptive immune responses.
    Ma Z; Zhang E; Yang D; Lu M
    Cell Mol Immunol; 2015 May; 12(3):273-82. PubMed ID: 25418467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral administered particulate yeast-derived glucan promotes hepatitis B virus clearance in a hydrodynamic injection mouse model.
    Yu X; Zhang D; Shi B; Ren G; Peng X; Fang Z; Kozlowski M; Zhou X; Zhang X; Wu M; Wang C; Yuan Z
    PLoS One; 2015; 10(4):e0123559. PubMed ID: 25856080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic recovery of hepatitis B virus (HBV)-induced hepatocyte-intrinsic immune defect reverses systemic adaptive immune tolerance.
    Lan P; Zhang C; Han Q; Zhang J; Tian Z
    Hepatology; 2013 Jul; 58(1):73-85. PubMed ID: 23447417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous or Prior Activation of Intrahepatic Type I Interferon Signaling Leads to Hepatitis B Virus Persistence in a Mouse Model.
    Zou S; Du Y; Huang S; Chen M; Yang X; Li S; Chen Y; Han M; Li J; Yu Q; Littwitz-Salomon E; Huang H; Trilling M; Liu S; Pei R; Liu J; Wang B; Zheng X; Lu M; Dittmer U; Sun S; Yang D; Wu J
    J Virol; 2021 Nov; 95(24):e0003421. PubMed ID: 34550772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR2 Stimulation Strengthens Intrahepatic Myeloid-Derived Cell-Mediated T Cell Tolerance through Inducing Kupffer Cell Expansion and IL-10 Production.
    Liu J; Yu Q; Wu W; Huang X; Broering R; Werner M; Roggendorf M; Yang D; Lu M
    J Immunol; 2018 Apr; 200(7):2341-2351. PubMed ID: 29459406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis B Virus Surface Antigen Activates Myeloid Dendritic Cells via a Soluble CD14-Dependent Mechanism.
    van Montfoort N; van der Aa E; van den Bosch A; Brouwers H; Vanwolleghem T; Janssen HLA; Javanbakht H; Buschow SI; Woltman AM
    J Virol; 2016 Jul; 90(14):6187-6199. PubMed ID: 27099316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dose of HBV genome contained plasmid has a great impact on HBV persistence in hydrodynamic injection mouse model.
    Li L; Li S; Zhou Y; Yang L; Zhou D; Yang Y; Lu M; Yang D; Song J
    Virol J; 2017 Oct; 14(1):205. PubMed ID: 29070073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toll-like receptor (TLR)-mediated innate immune responses in the control of hepatitis B virus (HBV) infection.
    Zhang E; Lu M
    Med Microbiol Immunol; 2015 Feb; 204(1):11-20. PubMed ID: 25550115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor necrosis factor-alpha blockage therapy impairs hepatitis B viral clearance and enhances T-cell exhaustion in a mouse model.
    Chyuan IT; Tsai HF; Tzeng HT; Sung CC; Wu CS; Chen PJ; Hsu PN
    Cell Mol Immunol; 2015 May; 12(3):317-25. PubMed ID: 25661729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low hepatitis B virus-specific T-cell response in males correlates with high regulatory T-cell numbers in murine models.
    Kosinska AD; Pishraft-Sabet L; Wu W; Fang Z; Lenart M; Chen J; Dietze KK; Wang C; Kemper T; Lin Y; Yeh SH; Liu J; Dittmer U; Yuan Z; Roggendorf M; Lu M
    Hepatology; 2017 Jul; 66(1):69-83. PubMed ID: 28295453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Toll-like receptor 2 in the immune response against hepadnaviral infection.
    Zhang X; Ma Z; Liu H; Liu J; Meng Z; Broering R; Yang D; Schlaak JF; Roggendorf M; Lu M
    J Hepatol; 2012 Sep; 57(3):522-8. PubMed ID: 22617154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lentiviral backbone-based hepatitis B virus replicon-mediated transfer favours the establishment of persistent hepatitis B virus infection in mice after hydrodynamic injection.
    Chuai X; Wang W; Chen H; Deng Y; Wen B; Tan W
    Antiviral Res; 2014 Jan; 101():68-74. PubMed ID: 24239872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of circulating TLR2/4 expression with CD3+/4+/8+ T cells and Treg cells in HBV-related liver cirrhosis.
    Lian JQ; Wang XQ; Zhang Y; Huang CX; Bai XF
    Viral Immunol; 2009 Oct; 22(5):301-8. PubMed ID: 19811087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between Hepatitis B Virus and Toll-Like Receptors: Current Status and Potential Therapeutic Use for Chronic Hepatitis B.
    Ma Z; Cao Q; Xiong Y; Zhang E; Lu M
    Vaccines (Basel); 2018 Jan; 6(1):. PubMed ID: 29337856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NK Cells Help Induce Anti-Hepatitis B Virus CD8+ T Cell Immunity in Mice.
    Zheng M; Sun R; Wei H; Tian Z
    J Immunol; 2016 May; 196(10):4122-31. PubMed ID: 27183639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.